Journal
INTERNATIONAL JOURNAL OF STROKE
Volume 12, Issue 1, Pages 9-12Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1747493016669849
Keywords
Ischemic stroke; thrombolysis; rt-PA; thrombectomy; dabigatran; idarucizumab
Categories
Funding
- Alberta Innovates [201300690] Funding Source: researchfish
Ask authors/readers for more resources
Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
